Description: LeMaitre Vascular, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of medical devices and implants for the treatment of peripheral vascular disease worldwide. Its products include embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters; perfusion catheters that temporarily perfuse blood and other liquids into the vasculature; carotid shunts to temporarily divert blood to the brain during the removal of plaque from the carotid artery; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy. The company also offers manual contrast injectors for the injection of contrast media into blood vessels; modeling catheters to apply radial pressure to the inside of an aortic stent graft for sealing; radiopaque tape to improve the precision of vascular and endovascular procedures; and remote endarterectomy devices to remove severe atherosclerotic blockages from the arteries of the leg. In addition, it provides valvulotomes for use as a bypass vessel to carry blood past diseased arteries to the lower leg or the foot; vascular grafts to bypass or replace diseased arteries; vascular patches that are synthetic and biological patches for use in closing incisions in a blood vessel; vein strippers for single-incision removal of varicose veins; and vessel closure systems to attach blood vessels for dialysis access. LeMaitre Vascular, Inc. markets its products through direct and indirect sales force, and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.
Home Page: www.lemaitre.com
LMAT Technical Analysis
63 Second Avenue
Burlington,
MA
01803
United States
Phone:
781 221 2266
Officers
Name | Title |
---|---|
Mr. George W. LeMaitre | Chairman & CEO |
Mr. David B. Roberts | Pres & Director |
Mr. Joseph P. Pellegrino Jr. | CFO, Treasurer, Sec. & Director |
Mr. Trent G. Kamke | Sr. VP of Operations |
Dr. George D. LeMaitre | Founder and Chairman of Scientific Advisory Board |
Ms. Laurie A. Churchill | Sr. VP & Gen. Counsel |
Ms. Kimberly L. Cieslak | VP of Marketing |
Mr. Daniel J. Mumford | Director of HR |
Mr. Andrew Hodgkinson | Sr. VP of Clinical, Regulatory & Quality Affairs |
Mr. Stephane Maier | Sr. VP of EMEA Operations |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 40.3226 |
---|---|
Trailing PE: | 48.4255 |
Price-to-Book MRQ: | 4.0406 |
Price-to-Sales TTM: | 6.2693 |
IPO Date: | 2006-10-19 |
Fiscal Year End: | December |
Full Time Employees: | 450 |